Disclosure Information

Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Current Chairs


Personal Financial Relationships: Dr. Ghany serves on an advisory board for Merck & Co, Inc (uncompensated).
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Dr. Marks was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Dr. Morgan was awarded research grants, paid to his institution, from AbbVie, Genfit, Gilead Sciences, Inc, Merck & Co, Inc, and Roche.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Dr. Wyles was awarded research grants, paid to his institution, from Gilead Sciences Inc.
Updated: 11/13/2018

Current Panel Members


Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/29/2018

Personal Financial Relationships: Dr. Feld serves as a scientific consultant to AbbVie, ContraVir Pharmaceuticals, Enanta, Merck & Co Inc, and Gilead Sciences Inc.
Institutional Research: Dr. Feld was awarded research grants paid to his institution from AbbVie, Gilead Sciences, Inc, Janssen, Merck & Co Inc, and Wako.
Updated: 11/13/2018

Personal Financial Relationships: Dr. Gordon serves on scientific advisory boards for AbbVie and Gilead Sciences, Inc.
Institutional Research: Dr. Gordon was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: Dr. Jhaveri serves as a scientific consultant for MedImmune/AstraZeneca.
Institutional Research: Dr. Jhaveri received research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc (ceased as of October 1, 2018).
Updated: 11/13/2018

Personal Financial Relationships: Dr. Jonas serves as a scientific consultant to Gilead Sciences, Inc.
Institutional Research: Dr. Jonas was awarded research grants, paid to her institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Merck & Co, Inc, and Roche.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Dr. Kiser was awarded research grants, paid to her institution, from Janssen Therapeutics, Inc, ViiV Healthcare, and Gilead Sciences.
Updated: 11/16/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: Dr. Peters' husband is an employee/officer/director and has stock options at Hoffman La Roche.
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: Dr. Reddy serves on advisory boards for AbbVie, Gilead Sciences, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc.
Institutional Research: Dr. Reddy was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Mr. Reynolds’s organization was awarded educational grants from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Bristol-Myers Squibb, Janssen, Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: Dr. Terrault serves on the medical affairs boards of Gilead Sciences, Inc (uncompensated) and Merck & Co, Inc. She serves on the marketing advisory boards of AbbVie (uncompensated) and on the scientific advisory board of Biotest. She also serves as a consultant to AbbVie, Biotest, CoCrystal Pharmaceuticals, and Gilead Sciences, Inc.
Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from AbbVie, Gilead Sciences, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc.
Updated: 11/13/2018

Personal Financial Relationships: Dr. Trooskin is a consultant for Gilead Sciences, Inc.
Institutional Research: Dr. Trooskin was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Gilead Sciences Foundation.
Updated: 11/13/2018

Personal Financial Relationships: Dr. Verna serves on an advisory board of Gilead Sciences, Inc.
Institutional Research: Dr. Verna was awarded research grants paid to her institution from Salix Pharmaceuticals.
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: None
Updated: 11/13/2018

Personal Financial Relationships: None
Institutional Research: Dr. Workowski was awarded research grants, paid to her institution, from AbbVie, Bristol-Myers Squibb, and Gilead Sciences, Inc.
Updated: 11/13/2018

Top